Ibogaine
Ibogaine Treatment
A comprehensive, evidence-led resource on ibogaine: pharmacology, the research base, cardiac risk, candidacy, preparation and integration.
Ibogaine integration
On the evidence available, what happens in the weeks after an ibogaine experience matters more to the outcome than the experience itself. Integration is the structured work of sleep, nutrition, behaviour, environment, relationships and continuing support.
Why integration
Prospective observational studies of ibogaine treatment for opioid dependence report reductions in use and withdrawal severity over twelve months in some participants, with considerable variation. Those studies cannot establish cause, but they are reasonably consistent about one association: outcomes were generally better among people whose circumstances, structure and support changed afterwards.
That is not a surprising finding, and it is the opposite of how ibogaine is often marketed. A single administration presented as sufficient in itself is a claim the literature does not support, and it sets people up to interpret a return of difficulty as personal failure rather than as the predictable consequence of an unchanged life.
Integration is therefore not an add-on. It is the period in which the conditions for change are either built or allowed to collapse. The work includes reflection, behaviour, environment, relationships, meaning and, where relevant, medical and psychological continuity.
Integration does not guarantee an outcome either. It improves the conditions under which change is possible. Nobody here will tell you that following a plan produces a guaranteed result.
Integration is planned during preparation, and the wider evidence context is set out on the ibogaine treatment guide. The principles also overlap with psychedelic therapy more broadly.
Domains
Effective integration is multi-domain. Each area below influences the others, and none of them can be outsourced entirely to a single conversation or a single practitioner. The question is whether the days and weeks after treatment are organised around these domains deliberately.
Extended, autobiographical material does not organise itself. Structured sessions in the days afterwards turn what surfaced into something a person can describe, question and act on.
Sleep disruption and insomnia are commonly reported after ibogaine and can persist for several days. Restoring sleep is treated as a clinical priority rather than waited out, because almost every other domain depends on it.
People frequently arrive nutritionally depleted after a period of heavy substance use. Rebuilding intake deliberately supports recovery of energy, mood stability and cognitive function.
The specifics of daily life — what the first two hours of the day contain, what the evenings contain, what is done instead of the old pattern. Vague intentions do not survive contact with an unchanged routine.
Physical and social environment is one of the strongest predictors of what happens next in the observational literature. Returning to precisely the setting the pattern was built in makes change substantially harder.
Which relationships support the change, which do not, and what conversations need to happen. This is often the most difficult part and the most consequential.
Many people describe the experience as clarifying what they want their life to contain. Integration is where that either becomes concrete commitments or dissipates into a memory.
Continuing care — therapeutic, medical or peer — planned before discharge and coordinated with the person's own clinicians where they consent to it.
Where dependence is involved, explicit planning including the fact that reduced tolerance after abstinence sharply increases overdose risk if opioid use resumes. This is stated directly, not implied.
A practical frame
The days after ibogaine can be physically and emotionally uneven. Sleep may be fragmented, appetite may return slowly, and old memories or feelings may surface with unusual intensity. A structured integration plan anticipates this rather than treating it as unexpected.
Mental health support is part of that structure. For people with PTSD, depression or trauma histories, the material that emerges can be destabilising if it is not held in a therapeutic relationship. Individual sessions, appropriate medical follow-up and coordination with the person's existing clinicians provide continuity.
Behavioural change is where insight meets friction. The patterns a person returns to — relationships, work rhythms, evening routines, digital habits — are often the same patterns that preceded the crisis. Integration examines those patterns practically and replaces them with alternatives that are specific enough to survive the first difficult week.
Returning to the exact environment in which a dependence or mental-health pattern developed is one of the highest-risk decisions in early integration. When a return is unavoidable, the plan includes boundaries, schedules and support contacts that reduce the environmental load.
Many people describe ibogaine as clarifying what they want their life to contain. That clarity is valuable, but it is fragile. Integration turns it into concrete commitments — relationships to repair, work to begin or end, health behaviours to maintain — before the feeling fades.
Questions
Integration is the structured period after an ibogaine experience in which insights, memories and physical changes are translated into daily practice. It includes psychological processing, sleep restoration, nutrition, behaviour change, environment, relationships and ongoing professional support.
There is no fixed endpoint. The first several weeks are typically the most intensive, because sleep, mood and behaviour are still stabilising. Many people continue some form of structured support for months, and the evidence suggests that what happens in the first twelve weeks is particularly important.
No. Integration improves the conditions under which change is possible, but it does not guarantee any outcome. Ibogaine research is observational and early-phase; no programme can promise a specific result.
Some people report lasting shifts in mood, perspective and trauma-related symptoms, but these reports are not the same as clinical proof. Integration provides a supportive structure for whatever arises, and mental health support is included precisely because difficult material can surface.
Sleep disruption is one of the most commonly reported effects in the days after ibogaine. Poor sleep impairs decision-making, emotional regulation and motivation, so restoring sleep is treated as a clinical priority rather than a minor inconvenience.
A return of difficulty is not a personal failure; it is information. A plan made in advance — including contact with clinicians, peer support and, where relevant, medication — makes it easier to respond early rather than reactively.
It is strongly advisable. Ibogaine can surface complex psychological and medical material. Therapeutic, medical or peer support coordinated with the person's own clinicians provides continuity and safety.
For people whose ibogaine treatment involved opioid dependence, relapse prevention includes explicit planning about reduced tolerance. After a period of abstinence, the same dose that was previously tolerated can become lethal, so this risk is discussed directly and planned for.
References
Explore
Related
Ibogaine
A comprehensive, evidence-led resource on ibogaine: pharmacology, the research base, cardiac risk, candidacy, preparation and integration.
Psychedelic Therapy
An editorial review of what the psychedelic research actually shows, compound by compound, with the screening and safety considerations that come with it.
Ibogaine
Medical, psychological and practical preparation: history, medication review, ECG, laboratory assessment, consent and integration planning.
Ibogaine
A consumer guide to evaluating an ibogaine provider: screening, cardiac assessment, medical oversight, emergency preparedness and transparency.
Insights
Benzodiazepine Treatment
Benzo detox and withdrawal treatment: a physician-directed taper, twenty-four hour monitoring, nine hours of daily therapy and the in-house Brain Repair IV protocol.
Ibogaine
A consumer guide to evaluating an ibogaine provider: screening, cardiac assessment, medical oversight, emergency preparedness and transparency.
Benzodiazepine Treatment
Physician-supervised benzodiazepine detox and withdrawal support: gradual tapering, nine hours of daily one-to-one therapy, the in-house Brain Repair IV protocol, and whole-body restoration in a private oceanfront setting.
Mental Health
An integrative approach to PTSD, trauma, depression and anxiety that treats sleep, nutrition, environment and behavior as clinical variables.
Holistic Treatment
Rehabilitation as system repair: mental health, behavior, environment, nutrition and sleep, with specialized medical support where it is needed.
Ibogaine
Medical, psychological and practical preparation: history, medication review, ECG, laboratory assessment, consent and integration planning.
Ibogaine
QT prolongation, arrhythmia risk, CYP2D6 metabolism, drug interactions and electrolytes — what the safety literature establishes and what remains uncertain.
Ibogaine
A comprehensive, evidence-led resource on ibogaine: pharmacology, the research base, cardiac risk, candidacy, preparation and integration.
Admissions is a confidential clinical conversation, not a sales call. We review history, current medication, and goals before anyone is accepted.